Our patients can schedule a COVID-19 vaccination through NYU Langone Health MyChart or the NYU Langone Health app. Learn more about the COVID-19 vaccine. Read our updated information about wearing a mask for your visit.

If you need help accessing our website, call 855-698-9991
Skip to main content
Steven Goldstein at [NYU Langone Health]
Affiliated Provider
Affiliated providers provide medical care at an NYU Langone location or a private practice, and are not employed by NYU Langone Health.

Steven R. Goldstein, MD

Affiliated Provider
Affiliated providers provide medical care at an NYU Langone location or a private practice, and are not employed by NYU Langone Health.
View Locations

I am an old-fashioned diagnostician; no, actually, I am a dinosaur. I do not have a six-page medical history form that is emailed to you before your first visit and then scanned into the computer. I ask you questions, in my compulsively ordered fashion, about your medical history, face-to-face. 

When you call my office, you never hear, “press one for appointments, press two for billing.” I talk to patients in my consultation room after they are dressed and full of questions following an examination, no matter how trivial or complex the reason for the visit. 

My education, training, credentials, and publications demonstrate that I am an expert in vaginal ultrasounds for abnormal bleeding, ovarian masses, fibroids, and, essentially, all things gynecological. 

I seem to be the referral person for people who have been told they need surgery elsewhere but want more than just “a second opinion.” I developed a catheter to put a tablespoon of sterile saline into the uterus, so women with abnormal uterine bleeding can avoid unnecessary biopsies, dilations and curettage procedures, and hysterectomies.

I listen to patients. I use ultrasound liberally when solving problems. I partner with patients who want to be healthy and stay healthy. I believe in using experience, judgment, and individualization—not medicine by a “clinical pathway,” or what you might call “formulaic.”

I have been an examiner for the American Board of Obstetrics and Gynecology, giving exams to those who are trying to become Board certified. I teach students and residents about obstetrics and gynecology. I lecture all over the world to doctors in practice. I am active in all aspects of gynecology. I welcome the opportunity to use my experience and expertise to help you, no matter how big or small your gynecologic concerns may be.

Conditions and Treatments

  • abnormal pap smear
  • fibroid tumor
  • hot flash
  • menopause
  • menstrual disorder
  • osteoporosis
  • premenopause
  • uterine bleeding
  • vaginal atrophy
  • abortion
  • annual GYN screening
  • birth control
  • diagnostic imaging
  • gynecological surgery
  • hysteroscopy
  • osteoporosis screening
  • ovarian cancer screening

Board Certifications
  • American Board of Obstetrics & Gynecology - Obstetrics & Gynecology, 1983
Education and Training
  • Residency, NYU Medical Center, Obstetrics & Gynecology, 1980
  • MD from New York University, 1975

Is this your profile?

Edit profile

Locations and Appointments

314 East 34th Street, 5th Floor
New York, NY 10016


Abnormal Uterine Bleeding, Ultrasound, Adnexal Masses, Serum Estrogen Receptor Modulators (SERMs), Menopause, Sonohysterography

Research Summary

I believe my clinical research has had a significant influence on the way gynecology is practiced.

In 1991, I was the first to suggest that a thin, distinct endometrial echo on transvaginal ultrasound in postmenopausal bleeding did not indicate the need for a biopsy. This was finally adopted as the standard of care by the American Congress of Obstetricians and Gynecologists (ACOG) in 2009.

In 1989, I was the first to suggest that simple cysts of postmenopausal ovaries were benign and did not require surgical intervention. In 2009 that, too, became the standard of care.

In 1994, I first described endometrial fluid collections on vaginal sonograms as a naturally occurring, de facto sonohysterogram and determined that when tissue surrounding the fluid is thin, endometrial disease can be excluded.

Also in 1994, I was the first to describe the glandular cystic atrophy causing an unusual ultrasound appearance in women receiving tamoxifen, and have since been involved in the study of—and have published research on—practically every selective estrogen-receptor modulator, including raloxifene, lasofoxifene, levormeloxifene, arzoxifene, and ospemifene.

I was the first, in 2004, to warn against unnecessary biopsy in nonbleeding postmenopausal patients with an incidental finding of thick endometrial lining on vaginal sonogram, which was affirmed by ACOG in its Practice Bulletin in 2009, and reaffirmed in 2015.

Since 1995, I have argued against blind endometrial biopsies. I also championed saline infusion sonohysterogram—which was finally endorsed by ACOG in its Practice Bulletin in 2012.

Academic Contact

Academic office

314 East 34th Street

5th Floor

New York, NY 10016



These focus areas and their associated publications are derived from PubMed and the MeSH term library. *
represents one publication
*Due to PubMed processing times, the most recent publications may not be reflected in the timeline.

Read All Publications (183)